SwePub
Sök i LIBRIS databas

  Utökad sökning

L773:0344 0338
 

Sökning: L773:0344 0338 > (2020-2024) > In vitro anti-cance...

  • Paudel, Keshav RajCentenary Inst, Ctr Inflammat, Sydney, NSW 2007, Australia.;Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW 2007, Australia. (författare)

In vitro anti-cancer activity of a polyherbal preparation, VEDICINALS®9, against A549 human lung adenocarcinoma cells

  • Artikel/kapitelEngelska2023

Förlag, utgivningsår, omfång ...

  • Elsevier,2023
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-518359
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-518359URI
  • https://doi.org/10.1016/j.prp.2023.154832DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • PurposeNon-small cell lung cancer (NSCLC) is among the leading causes of morbidity and mortality worldwide. Despite the availability of several treatment options, the five-year survival rate of NSCLC is extremely low (<20%). This underlines the necessity of more effective therapeutic alternatives. In this context, plant-derived extracts and bioactive molecules extracted from plants, known collectively as phytoceuticals, represent an extremely variegated source of bioactive compounds with potent anticancer potential. In the present study, we tested the in vitro anticancer activity of a polyherbal preparation, VEDICINALS®9, containing nine different bioactive principles extracted by medicinal plants.MethodsThe anticancer activity of VEDICINALS®9 was investigated by measuring its impact on A549 human NSCLC cell proliferation (MTT assay and trypan blue staining), migration (wound healing assay and transwell chamber assay) and by measuring the impact on the expression of cancer-related proteins (Human XL Oncology Protein Array).ResultsWe show that VEDICINALS®9 at a concentration of 0.2% v/v has potent anticancer effect, significantly inhibiting A549 cell proliferation and migration. Mechanistically, this was achieved by downregulating the expression of proteins involved in cancer cell proliferation (Axl, FGF basic, enolase 2, progranulin, survivin) and migration (Dkk-1, cathepsins B and D, BCL-x, amphiregulin, CapG, u-plasminogen activator). Furthermore, treatment with VEDICINALS®9 resulted in increased expression of the oncosuppressor protein p53 and of the angiogenesis inhibitor endostatin.ConclusionsTaken together, our results provide proof of principle of the potent anticancer activity of the polyherbal preparation VEDICINALS®9, highlighting its enormous potential as an alternative or adjuvant therapy for lung cancer.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Rajput, RashiUniv Technol Sydney, Grad Sch Hlth, Discipline Pharm, Sydney, NSW 2007, Australia. (författare)
  • De Rubis, GabrieleUniv Technol Sydney, Grad Sch Hlth, Discipline Pharm, Sydney, NSW 2007, Australia.;Univ Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Fac Hlth, Ultimo, NSW 2007, Australia. (författare)
  • Allam, Venkata Sita Rama RajuUppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi(Swepub:uu)venal651 (författare)
  • Williams, Kylie AnneUniv Technol Sydney, Grad Sch Hlth, Discipline Pharm, Sydney, NSW 2007, Australia. (författare)
  • Singh, Sachin KumarUniv Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Fac Hlth, Ultimo, NSW 2007, Australia.;Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara, Punjab, India. (författare)
  • Gupta, GauravSuresh Gyan Vihar Univ, Sch Pharm, Jaipur, Rajasthan, India.;Saveetha Univ, Saveetha Inst Med & Tech Sci, Saveetha Med Coll, Ctr Global Hlth Res, Chennai, India.;Graph Era Hill Univ, Sch Pharm, Dehra Dun 248007, India. (författare)
  • Salunke, PrakashVedicinals India Pvt Ltd, Pune, Maharashtra, India. (författare)
  • Hansbro, Philip MichaelCentenary Inst, Ctr Inflammat, Sydney, NSW 2007, Australia.;Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW 2007, Australia. (författare)
  • Gerlach, JoachimVedicinals India Pvt Ltd, Pune, Maharashtra, India.;Verbindungsstr 21, D-40764 Langenfeld, Germany. (författare)
  • Dua, KamalUniv Technol Sydney, Grad Sch Hlth, Discipline Pharm, Sydney, NSW 2007, Australia.;Univ Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Fac Hlth, Ultimo, NSW 2007, Australia.;POB 123, Broadway, NSW 2007, Australia. (författare)
  • Centenary Inst, Ctr Inflammat, Sydney, NSW 2007, Australia.;Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW 2007, Australia.Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Sydney, NSW 2007, Australia. (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Pathology, Research and Practice: Elsevier2500344-03381618-0631

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy